Skip Ribbon Commands
Skip to main content
Sign In
Skip Navigation LinksCVMBS Home > Veterinary Teaching Hospital > For Veterinarians > Clinical Trials > Efficacy of Cyclosporine for the Treatment of Immune-mediated Chronic Hepatitis and Penicillamine for the Treatment of Copper Associated Hepatopathy in Dogs
Efficacy of Cyclosporine for the Treatment of Immune-mediated Chronic Hepatitis and Penicillamine for the Treatment of Copper Associated Hepatopathy in Dogs

Return to the Clinical Trials homepage.

Who qualifies?

Dogs with elevated liver enzymes that may have immune-mediated chronic hepatitis or copper associated hepatopathy or are newly diagnosed and untreated.

Purpose of the study

The aim of this study is to assess the efficacy of cyclosporine in the treatment of immune-mediated chronic hepatitis and penicillamine in the treatment of copper associated hepatopathy in dogs.

What is required?

  • Elevated liver values
  • Baseline bloodwork and urine, liver ultrasound and aspirate, liver biopsy (ideally performed at CSU) confirming diagnosis of immune-mediated chronic hepatitis or copper associated hepatopathy
  • 1, 3, and 6 month rechecks, repeat liver biopsy at 6 months

Benefits

1, 3, and 6 month rechecks related to the study will be covered, except for the cost of medications and diet. The study will also cover a repeat liver biopsy at 6 months.

To enroll:

Interested participants can learn more by contacting one of our research investigators by emailing Dr. Tarini Ullal, tvullal@colostate.edu.

dog
Make a Gift and Support the VTH
Contact Us:
Colorado State University
Veterinary Teaching Hospital
300 West Drake Road
Fort Collins, Colorado, 80523​​

Phone:
(970) 297-5000

Fax:
(970) 297-1205